A novel de novo microdeletion at 17q11.2 adjacent to NF1 gene associated with developmental delay, short stature, microcephaly and dysmorphic features
- PMID: 27247625
- PMCID: PMC4886423
- DOI: 10.1186/s13039-016-0251-y
A novel de novo microdeletion at 17q11.2 adjacent to NF1 gene associated with developmental delay, short stature, microcephaly and dysmorphic features
Abstract
Background: Microdeletions at 17q11.2 often encompass NF1 gene, is the cause for NF1 microdeletion syndrome. Microdeletion at 17q11.2 without the involvement of NF1 gene is rarely reported.
Case presentation: Here we reported a patient carrying a novel de novo deletion at 17q11.2 adjacent to NF1 gene, who presented with developmental delay, short stature, postnatal microcephaly, underweight and dysmorphic features including flat facial profile, dolicocephaly, hypertelorism, short philtrum, flat nasal bridge and posteriorly rotated and low set ears. Chromosomal microarray analysis revealed a 1.69 Mb de novo deletion at 17q11.2 adjacent to NF1 gene, which involves 43 RefSeq genes. We compared this with four overlapping deletions at this interval.
Conclusions: A rare de novo microdeletion at 17q11.2 not involving NF1 gene is associated with developmental delay and dysmorphic features. Seven genes, TAOK1, PHF12, NUFIP2, SLC26A4, SEZ6, GIT1 and TRAF4 are possible candidates for the clinical features of our patient. The delineation of this rare deletion and description of associated clinical phenotypes will help to understand the genotype-phenotype correlation of genomic imbalances at this locus.
Keywords: 17q11.2; Chromosomal microarray; Developmental delay; Microcephaly; Microdeletion; SNP array; Short stature.
Figures


Similar articles
-
NF1 microdeletion syndrome: case report of two new patients.Ital J Pediatr. 2019 Nov 8;45(1):138. doi: 10.1186/s13052-019-0718-7. Ital J Pediatr. 2019. PMID: 31703719 Free PMC article.
-
Two independent chromosomal rearrangements, a very small (550 kb) duplication of the 7q subtelomeric region and an atypical 17q11.2 (NF1) microdeletion, in a girl with neurofibromatosis.Cytogenet Genome Res. 2007;119(1-2):158-64. doi: 10.1159/000109634. Epub 2007 Dec 14. Cytogenet Genome Res. 2007. PMID: 18160797
-
Genotype-Phenotype Associations in Patients With Type-1, Type-2, and Atypical NF1 Microdeletions.Front Genet. 2021 Jun 8;12:673025. doi: 10.3389/fgene.2021.673025. eCollection 2021. Front Genet. 2021. PMID: 34168676 Free PMC article.
-
Emerging genotype-phenotype relationships in patients with large NF1 deletions.Hum Genet. 2017 Apr;136(4):349-376. doi: 10.1007/s00439-017-1766-y. Epub 2017 Feb 17. Hum Genet. 2017. PMID: 28213670 Free PMC article. Review.
-
Classification of NF1 microdeletions and its importance for establishing genotype/phenotype correlations in patients with NF1 microdeletions.Hum Genet. 2021 Dec;140(12):1635-1649. doi: 10.1007/s00439-021-02363-3. Epub 2021 Sep 18. Hum Genet. 2021. PMID: 34535841 Free PMC article. Review.
Cited by
-
Clinical and Neurobiological Aspects of TAO Kinase Family in Neurodevelopmental Disorders.Front Mol Neurosci. 2021 Mar 24;14:655037. doi: 10.3389/fnmol.2021.655037. eCollection 2021. Front Mol Neurosci. 2021. PMID: 33867937 Free PMC article.
-
The Role of ER Stress-Related Phenomena in the Biology of Malignant Peripheral Nerve Sheath Tumors.Int J Mol Sci. 2021 Aug 30;22(17):9405. doi: 10.3390/ijms22179405. Int J Mol Sci. 2021. PMID: 34502310 Free PMC article. Review.
-
NF1 microdeletion syndrome: case report of two new patients.Ital J Pediatr. 2019 Nov 8;45(1):138. doi: 10.1186/s13052-019-0718-7. Ital J Pediatr. 2019. PMID: 31703719 Free PMC article.
-
Rare NF1 microdeletion syndrome in an Omani patient.Clin Case Rep. 2018 Oct 26;6(12):2424-2426. doi: 10.1002/ccr3.1881. eCollection 2018 Dec. Clin Case Rep. 2018. PMID: 30564341 Free PMC article.
-
TAOK1 is associated with neurodevelopmental disorder and essential for neuronal maturation and cortical development.Hum Mutat. 2021 Apr;42(4):445-459. doi: 10.1002/humu.24176. Epub 2021 Mar 1. Hum Mutat. 2021. PMID: 33565190 Free PMC article.
References
-
- Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749–64. doi: 10.1016/j.ajhg.2010.04.006. - DOI - PMC - PubMed
-
- Sagoo GS, Butterworth AS, Sanderson S, Shaw-Smith C, Higgins JP, Burton H. Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects. Genet Med. 2009;11(3):139–46. doi: 10.1097/GIM.0b013e318194ee8f. - DOI - PubMed
-
- Hochstenbach R, van Binsbergen E, Engelen J, Nieuwint A, Polstra A, Poddighe P, et al. Array analysis and karyotyping: workflow consequences based on a retrospective study of 36,325 patients with idiopathic developmental delay in the Netherlands. Eur J Med Genet. 2009;52(4):161–9. doi: 10.1016/j.ejmg.2009.03.015. - DOI - PubMed
-
- Kehrer-Sawatzki H, Kluwe L, Sandig C, Kohn M, Wimmer K, Krammer U, et al. High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene. Am J Hum Genet. 2004;75(3):410–23. doi: 10.1086/423624. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous